Showing results (21-30 of 1,694) with videos related to

Sort By:
Pageof 170
L'Encephale|August 6, 1999
[Clinical tolerance of a new antidepressant -- milnacipran]W Regina, P Vandel, S Vandel, et al.
L'Encephale|July 1, 1985
[Dexamethasone test: suppressors and non-suppressors, what's the difference?]S Vandel, B Bonin, B Vandel, et al.
European Journal of Clinical Pharmacology|January 1, 1982
Biotransformation of amitriptyline in depressive patients: urinary excretion of seven metabolitesB Vandel, M Sandoz, S Vandel, et al.
European Journal of Clinical Pharmacology|January 1, 1982
Relationship between the plasma concentration of clomipramine and desmethylclomipramine in depressive patients and the clinical responseB Vandel, S Vandel, J M Jounet, et al.
L'Encephale|January 1, 1981
[Clomipramine and desmethylclomipramine: relationship between plasma levels and clinical effect (author's transl)]B Vandel, S Vandel, J M Jounet, et al.
Pharmacopsychiatry|July 1, 1989
Desipramine dose prediction based on 24-hour single-dose levels: feasibility and validityG Bertschy, S Vandel, B Vandel, et al.
Pharmacopsychiatry|November 1, 1990
Desipramine induces cardiac beta-adrenergic sensitivity decrease in major depressed patients without relationship to therapeutic responseG Bertschy, S Vandel, A Puech, et al.
L'Encephale|June 30, 2000
[Extrapyramidal side effects of neuroleptic and antidepressant treatment: assessment of potential risk factors through CYP2D6 genetic polymorphism]K Reggiani, P Vandel, E Haffen, et al.
Neuropsychobiology|January 1, 1989
Cardiac beta-adrenergic sensitivity in depression: relation with endogenous subtype and desipramine responseG Bertschy, S Vandel, A Puech, et al.
European Journal of Clinical Pharmacology|November 27, 1978
Clinical response and plasma concentration of amitriptyline and its metabolite nortriptylineS Vandel, B Vandel, M Sandoz, et al.
Pageof 170